High‐sensitivity <scp>C</scp>‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the <scp>EXAMINE</scp> (<scp>Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care</scp>) trial
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism